Curcumin enhances mycobacterial clearance in diabetes-tuberculosis by targeting the WNT6
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.158753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Hailin Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen University Medical School, Shenzhen, China. Hauptthemen laut MEDLINE: Curcumin, Diabetes Mellitus, Type 2, Tuberculosis, Wnt Proteins. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Major Science and Technology Projects of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: The convergence of tuberculosis (TB) and diabetes mellitus (DM) represents a critical global health challenge. Chronic hyperglycemia compromises macrophage bactericidal capacity, leading to excessive reactive oxygen species (ROS) accumulation and proinflammatory microenvironment that causing pathological damage to the lungs and paradoxically favors Mtb survival. OBJECTIVE: This study aimed to investigate the therapeutic potential of curcumin in mitigating metabolic-immune dysfunction in DM-TB comorbidity via WNT6-mediated macrophage modulation. METHODS: This study established a Type 2 Diabetes (T2D) mouse model using C57BL/6 mice, Mice were infected with H37Rv via inhalation, followed by curcumin administration. Various methodologies were employed, including RNA sequencing, flow cytometry, seahorse and Confocal Microscopy. THP-1 cells and bone marrow-derived macrophages (BMDMs) were differentiated and used for infection studies, assessing cell viability and intracellular bacterial burden. RESULTS: Curcumin effectively reversed the pathological alterations associated with hyperglycemia. Specifically, it suppressed WNT6 expression, reduced lipid droplet formation, and decreased FAO in macrophages. Additionally, curcumin mitigated oxidative stress, restored immune homeostasis, and enhanced Mtb clearance. CONCLUSION: Curcumin emerged as a viable intervention for strengthening host defense against TB in diabetic populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen University Medical School, Shenzhen, China.
- Gannan Medical University, Ganzhou, China.
- Shenzhen University Medical School, Shenzhen, China; School of Pharmacy, Shenzhen University, Shenzhen, China.
- Department of Clinical Laboratory, Shenzhen Baoan hospital, Shenzhen, China.
- The Seventh Affiliated Hospital Sun Yat-sen University, Shenzhen, China.
- National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Förderung
- National Natural Science Foundation of China
- National Major Science and Technology Projects of China
Zitieren
APA
Lu, H., Liu, G., Li, W., Xu, Y., Li, J., Lin, J., Zeng, L., Yang, Q., Yang, J., Deng, G., Chen, X., & Wang, W. (2026). Curcumin enhances mycobacterial clearance in diabetes-tuberculosis by targeting the WNT6. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158753
Vancouver
Lu H, Liu G, Li W, Xu Y, Li J, Lin J, et al. Curcumin enhances mycobacterial clearance in diabetes-tuberculosis by targeting the WNT6. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158753
BibTeX
@article{Lu2026,
author = {Lu, Hailin and Liu, Guizhen and Li, Wensi and Xu, Yuzhong and Li, Jin and Lin, Jingyan and Zeng, Lina and Yang, Qianting and Yang, Jiahuan and Deng, Guofang and Chen, Xinchun and Wang, Wenfei},
title = {Curcumin enhances mycobacterial clearance in diabetes-tuberculosis by targeting the WNT6},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.158753}
}
EUVIMED